A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and ...

Cognition Therapeutics Inc. (NASDAQ:CGTX) saw its stock climb sharply by 75% following a productive end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) concerning its Alzheimer’s ...

Following a Mediterranean diet long-term may have weight loss benefits but it may not be enough to enhance cognitive function ...

A recent study from UCLA identifies four distinct clusters of symptoms that can progress to Alzheimer's disease, offering new ...

As Alzheimer's disease progresses, behavioral and psychiatric issues become common, distressing, and even dangerous for ...

As Alzheimer's disease progresses beyond the early stages, the behavior changes and emotional impacts of the disease can be ...

Fruit is filled with nutrients and antioxidants that may help you live longer. Dietitians say sweet, juicy blueberries are ...

Investing.com -- Cognition Therapeutics Inc (NASDAQ: CGTX) stock surged 75% following the company’s end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) regarding its Alzheimer’s ...

We spoke to the first author of a new study that could challenge much of what we thought we knew about Alzheimer’s disease.

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.

People with “young” brains — brains aging more slowly than their actual age — are much less likely to die or develop ...

WHEN Pola Walotka asked ‘Mummy, will they get better?’ her mother Marta was forced to give her a heartbreaking answer.  Tragically, she had to tell her seven-year-old daughter that her triplet ...